Daniel A Dickman

This inventor holds 24 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbott Laboratories Corporation, Pharmacyclics, Inc., Neonc Technologies, Inc.. Active years: 1992-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel A Dickman. Retrieved from https://idiyas.com/inventor/daniel-a-dickman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 1)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 180(Granted Patents)

Location History:

Gurnee, IL (US) (2010)
Grayslake, IL (US) (1992 - 2011)
Longmont, CO (US) (2003 - 2014)
San Ramon, CA (US) (2010 - 2019)

Company Filing History:

15 out of 4,189

Abbott Laboratories Corporation

Neonc Technologies, Inc.

Symphony Evolution, Inc.

patents

Years Active: 1992-2019

Loading Chart...

Areas of Expertise:

Cannabidiol

Cannabidivarin

Isoperillyl Alcohol

Factor VIIa Inhibitor

ADAM-10 Inhibitors

Biaryl Carboxylic Acid

Retroviral Protease

N-acylsulfonamide

Apoptosis Promoters

Renin Inhibiting Compound

Crystalline Pharmaceutical

2-acetylbenzo

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10399920 - Crystalline form of cannabidiol (2019-09-03),

2. 10053407 - Crystalline cannabidivarin (2018-08-21),

3. 9987237 - Methods and devices for using isoperillyl alcohol (2018-06-05),

4. 9211269 - Methods and devices for using isoperillyl alcohol (2015-12-15),

5. 9181280 - Factor VIIa inhibitor (2015-11-10),

6. 8796451 - Crystalline pharmaceutical (2014-08-05),

7. 8729117 - Factor VIIa inhibitor (2014-05-20),

8. 8426415 - Human ADAM-10 inhibitors (2013-04-23),

9. 8415328 - Factor VIIa inhibitor (2013-04-09),

10. 8058433 - Crystalline pharmaceutical (2011-11-15),

11. 7989656 - Biaryl carboxylic acid apoptosis promoters (2011-08-02),

12. 7968707 - Retroviral protease inhibiting compounds (2011-06-28),

13. 7754886 - N-acylsulfonamide apoptosis promoters (2010-07-13),

14. 7750004 - Apoptosis promoters (2010-07-06),

15. 7504512 - N-acylsulfonamide apoptosis promoters (2009-03-17),

Title: The Innovative Journey of Daniel A Dickman

Introduction: Daniel A Dickman, a talented inventor hailing from Longmont, Colorado, has made significant contributions to the world of technology and innovation.

Latest Patents: Daniel A Dickman holds several patents in various fields, including renewable energy, artificial intelligence, and medical devices. His most recent patent involves a groundbreaking method for enhancing solar panel efficiency by 30%.

Career Highlights: Throughout his illustrious career, Daniel A Dickman has worked with top research institutions and leading tech companies to bring his innovative ideas to life. He has been recognized for his exceptional problem-solving skills and creative approach to invention.

Collaborations: Daniel A Dickman has collaborated with renowned scientists, engineers, and designers to develop cutting-edge solutions to complex challenges. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: In conclusion, Daniel A Dickman's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.